Adaptation of SFA for HRW

June 22, 2026 updated by: Suzannah Creech

Adapting Stress First Aid (SFA) to the Needs of Harm Reduction Workers (HRWs) Serving Persons Who Use Drugs (PWUD) - Training and Pilot Testing Phase (Aim 2 and Aim 3)

The aim of this study is to pilot and test the feasibility, acceptability, and effectiveness of a Stress First Aid (SFA) intervention adapted for Harm Reduction Workers (HRWs) serving Persons Who Use Drugs. The intervention consists of a training and learning collaboratives used to reinforce the SFA principles

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Austin, Texas, United States, 78712
        • The University of Texas at Austin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Legal age of majority (18 +),
  • Ability to read and speak conversational English, and
  • Work as an HRW in substance misuse.

Exclusion Criteria:

  • Inability to provide consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stress First Aid
Harm Reduction Workers received Stress First Aid training and learning collaboratives
Behavioral: Stress First Aid for Harm Reduction Workers
The intervention was a 2-hour, in-person SFA/HRW training followed by 30-minute monthly learning collaboratives to address occupational stress of harm reduction workers.
Other Names:
  • SFA/HRW

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Knowledge of Stress First Aid (SFA) Assessed by Stress First Aid Knowledge, Confidence, and Beliefs - Knowledge Sub-Scale at 4 Months
Time Frame: Assessed from enrollment to the end of the intervention at 4 months, 4 months reported
A 3-item, 5-point Likert type sub-scale of Stress First Knowledge, Confidence, and Beliefs Scale, developed by the developers of Stress First Aid (SFA), with a minimum score 1 "Does not describe me at all", maximum score 5 "Describes me very well", where a higher score is a better outcome.
Assessed from enrollment to the end of the intervention at 4 months, 4 months reported
Mean Confidence in Stress First Aid (SFA) Assessed by Stress First Aid Knowledge, Confidence, and Beliefs - Confidence Sub-Scale at 4 Months
Time Frame: Assessed from enrollment to the end of the intervention at 4 months, 4 months reported
A 6-item, 5-point Likert type sub-scale of Stress First Knowledge, Confidence, and Beliefs Scale, developed by the developers of Stress First Aid (SFA), with a minimum score 1 "Does not describe me at all", maximum score 5 "Describes me very well", where a higher score is a better outcome.
Assessed from enrollment to the end of the intervention at 4 months, 4 months reported
Mean Beliefs in Stress First Aid (SFA) Assessed by Stress First Aid Knowledge, Confidence, and Beliefs - Beliefs Sub-Scale at 4 Months
Time Frame: Assessed from enrollment to the end of the intervention at 4 months, 4 months reported
A 5-item, 5-point Likert type sub-scale of Stress First Knowledge, Confidence, and Beliefs Scale, developed by the developers of Stress First Aid (SFA), with a minimum score 1 "Does not describe me at all", maximum score 5 "Describes me very well", where a higher score is a better outcome.
Assessed from enrollment to the end of the intervention at 4 months, 4 months reported
Mean Acceptability of SFA Assessed by Acceptability of Intervention Measure (AIM)
Time Frame: Immediately after the 2-hour, in-person training.
A 4-item, 5-point Likert-type scale from Weiner et al., 2017, with a minimum score 1 "Completely disagree", maximum score 5 "Completely agree", where a higher score is a better outcome.
Immediately after the 2-hour, in-person training.
Mean Appropriateness of SFA Assessed by Intervention Appropriateness Measure (IAM)
Time Frame: Immediately after the 2-hour, in-person training.
A 4-item, 5-point Likert-type scale from Weiner et al., 2017, with a minimum score 1 "Completely disagree", maximum score 5 "Completely agree", where a higher score is a better outcome.
Immediately after the 2-hour, in-person training.
Mean Feasibility of SFA Assessed by Feasibility of Intervention Measure (FIM)
Time Frame: Immediately after the 2-hour, in-person training.
A 4-item, 5-point Likert-type scale from Weiner et al., 2017, with a minimum score 1 "Completely disagree", maximum score 5 "Completely agree", where a higher score is a better outcome.
Immediately after the 2-hour, in-person training.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Suzannah Creech

Collaborators

National Institute on Drug Abuse (NIDA)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 24, 2024

Primary Completion (Actual)

February 18, 2025

Study Completion (Actual)

February 18, 2025

Study Registration Dates

First Submitted

August 18, 2025

First Submitted That Met QC Criteria

August 22, 2025

First Posted (Actual)

August 29, 2025

Study Record Updates

Last Update Posted (Actual)

June 24, 2026

Last Update Submitted That Met QC Criteria

June 22, 2026

Last Verified

August 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • STUDY00006228
  • R61DA059887 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe